SpornM.The war on cancer. Lancet1996; 347:1377–1381.
2.
BeardsleyT.A war not won. Scientific American1994; January: 118–126.
3.
BurnettA, EdenO.The treatment of acute leukaemia. Lancet1997; 349: 270–275.
4.
GaleR, HoelzerC.Acute Lymphoblastic Leukemia. New York: Wiley Liss, 1990.
5.
RiehmH.Results and significance of six randomized trials in four consecutive ALL-BEM studies. In: KobayashiN, AkeraT, MizutaniS (eds). Childhood Leukemia: Present Problems and Future Prospects. London: Kluwer, 1991.
6.
RiceM.Progre ss in childhood cancer: can it be maintained? Med J Aust1994; 160: 326–331.
7.
GaytonP.Primary treatment of childhood acute lymphoblastic leukemia of non-T cell lineage (including infants). Hematol Oncol Clin North Am1990; 4: 915–936.
8.
ViettiR, LandV, ShusterJ, Progress against childhood cancer: the pediatric oncology group experience. Pediatrics1992; 89: 597–600.
9.
GreavesM.Stem cell origins of leukaemia and curability. Br J Cancer1993; 76(3): 413–423.
10.
AndrykowskiM, HensleeP, FarrallM.Physical and psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant1989; 4(1): 75–81.
11.
AuchinclossS.Sexual dysfunction after cancer treatment. J Psychosoc Oncol1991; 9(1): 23–43.
12.
DeegH.Delayed complications of marrow transplantation. Marrow Transplant Review1992; 2: 10–13.
13.
LenssenP, SherryM, CheneyM, Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. J Diet Assoc1990; 90: 835–842.
14.
BakerF, CurbowB, WingardJ.Role retention and quality of life of bone marrow transplant survivors. Soc Sci Med1991; 32(6): 697–704.
15.
BelecR.Quality of life: perceptions of long-term survivors of bone marrow transplantation. Oncol Nurs Forum1992; 19: 31–37.
16.
ChaoN, TierneyD, BloomJ, Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood1992; 80: 825–830.
17.
FerrellB, GrantM, SchmidtG, The meaning of quality of life for bone marrow transplant survivors: part 1. Cancer Nurs1992; 15: 247–253.
18.
StafeltA.Quality of life during induction treatment of acute myeloid leukaemia. Acta Oncol1994; 33(5): 477–485.
19.
EmanuelR, CollomsA, MendelsohnA, MullerH, TestaR.Psychotherapy with hospitalized children with leukemia: is it possible? J Child Psychother1990; 16(2): 21–37.
20.
FobairP, HoppeR, BloomJ, CoxR, VargheseA, SpiegelD.Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol1986; 4(5): 805–814.
21.
HengeveldM, HoutmanR, ZwaanF.Psychological aspects of bone marrow transplantation: a retrospective study of 17 long-term survivors. Bone Marrow Transplant1988; 4: 75–81.
22.
KornblithA, AndersonJ, CellaD, Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD. Cancer1992; 70: 2508–2516.
23.
MaguireG.The psychological sequelae of childhood leukemia. In: Recent Results of Cancer Research, Vol. 88. Berlin: Springer-Verlag, 1983.
24.
WolcottD, WellischD, FawzyF, Adaptation of adult bone marrow transplant recipient long-term survivors. Transplantation1986; 41(4): 478–483.
25.
ZaboraJ, SmithE, BakerF, WingardJ, CurbowB.The family: the other side of bone marrow transplantation. J Psychosoc Oncol1992; 10(1): 35–46.
26.
McGrathP.Chemotherapy, bioethics and social work — forging the link. Aust Social Work1997; 50(4): 53–60.
27.
McGrathP.Relocation for leukaemia treatment: a description of need. Aust Health Rev1998; 21(4): 143–154.
28.
McGrathP.Update on psychosocial research on leukaemia for social work practitioners. Social Work in Health Care1999; 29: 2..
29.
McGrathP.New directions in leukaemia research: a focus on psychosocial issues from a consumers’ perspective. Aust Social Work1999; 52(1): 39–45.
30.
BerteroC, EkA.Quality of life of adults with acute leukemia. J Adv Nurs1993; 18: 1346–1353.
31.
BerteroC, ErikssonB, EkA.Explaining different profiles in quality of life experiences in acute and chronic leukemia. Cancer Nurs1997; 20(2): 100–104.
32.
McGrathP.The question of choice: a bioethical perspective on chemotherapy. Cancer Forum1996; 20(2): 113–116.
33.
McGrathP, MarkmanM.Bioethical reflections on the limitations of cytotoxic drug use. Monash Bioethics Rev1996; 15(4): 9–14.
34.
McGrathP, KearsleyJ.Is there a better way? Bioethical reflections on palliative cytotoxic drug use. Palliat Med1995; 9(4): 269–271.
35.
MaddocksI, BentleyL, SheedyJ.Quality of life issues in patients dying from hematological diseases. Ann Acad Med Singapore1994; 23(2): 244–248.
36.
ManderT.Hematology and palliative care: an account of shared care for a patient undergoing bone marrow transplantation for chronic myeloid leukemia. Int J Nurs Pract1997; 3(1): 62–66.
37.
McGrathP.Accommodation for patients and carers during relocation for treatment for leukaemia: a descriptive profile. J Supportive Care Cancer1999; 7(1): 6–10.
38.
WaltersR, KantarjianH, KeatingM, Intensive treatment of acute leukemia in adults 70 years of age and older. Cancer1987; 60: 149–155.
39.
YatesJ, GlidewellO, WiernikP, Cytarabine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia. Blood1982; 60: 454–462.
40.
BernardP, LacombeF, ReiffersJ, Relationship between patient's age, bone marrow karyotype and outcome of induction therapy in acute myelogenous leukemia. Am J Hematol1985; 18: 1538.
41.
RaiK, HollandJ, GlidewellO, Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood1981; 58(6): 1203–1212.
42.
EllisonR, MickR, CuttnerJ, The effects of post-induction intensification treatment with cytarabine and daunorubicin in adult acute lymphoblastic leukemia. J Clin Oncol1991; 9(11): 2002–2015.
43.
EvensonS, BrinchL, StavernP, Survival in 91 adults with acute myelogenous leukemia treated with 1–6 intensive courses of chemotherapy. J Intern Med1992; 232: 433–437.
44.
ShapiroJ, BrownS, BriggsP, StanleyR, GriffithsJ, BrodieG, RichardsonG.Adult acute leukaemia — a retrospective study of 66 consecutive patients. Aust N Z J Med1997; 27: 301–306.
45.
StoneR, MayerR.The approach to the elderly patient with acute myeloid leukemia. Hematol Oncol Clin North Am1993; 7: 65–77.
46.
CopperstoneJ, PrenticeA.Acute myeloblastic leukemia in the elderly. Leuk Res1988; 12: 617–625.
47.
StockelbergD, LehtolaP, NorenI.Palliative treatment at home for patients with hematological disorders. Support Care Cancer1997; 5: 506–508.
48.
MunleyA.The Hospice Alternative. New York: Basic Books, 1983.
49.
PattisonE.The Experience of Dying. Englewood Cliffs, New Jersey: Prentice-Hall, 1977.
50.
CochraneJ, LevyM, FryerJ, OglesbyC.Death anxiety, disclosure behaviors, and attitudes of oncologists toward terminal care. Omega1990; 22(1): 1–12.